| Fuente | Nº Citas | Fecha Actualización |
|---|---|---|
| wos | 0 | 01-06-2025 |
Año: 2023
Journal Impact Factor (JIF): 12.50
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 21/322 | Q1 | T1 | D1 |
Año: 2023
Journal Citation Indicator (JCI): 1,990
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 30/322 | Q1 | T1 | D1 | 90,84 |
Año:
2023
CiteScore:
16,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 23/230 | Q1 | T1 | D1 |
| Oncology | 31/404 | Q1 | T1 | D1 |
SJR año:
2023
Factor de Impacto:
3,468
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 21/233 | Q1 | T1 | D1 |
| Oncology | 29/397 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Agencia Estatal de Investigacin | CEX2020-001024-S/AEI/10.13039/501100011033 |
| Agency for Management of University | PI21/01306 |
| AstraZeneca | 100010434; LCF/BQ/DI19/11730051; INVES20095LLOP |
| BBVA Foundation | AGAUR 2019 FI_B 01199; 2022 FI_B 00664 |
| Catalan Agency | PI17/01080; PI20/00892; PI23/00506; CPII19/00033 |
| Cellex Foundation | SLT017/20/000081 |
| FERO Foundation | AGAUR-FEDER (2021 SGR 01510) |
| Generalitat de Catalunya | - |
| German Federal Ministry of Education and Research (BMBF) | - |
| Instituto de Salud Carlos III | 01ZX1917A |
| Instituto de Salud Carlos III - European Union | - |
| La Caixa Foundation | PRE2021-099087 |
| Spanish Ministry of Science and Innovation | 2022 |
| State Agency for Research (Agencia Estatal de Investigacin) | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Pedretti, F | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 2 | Abdalfttah, M | Ctr Nacl Anal Genom CNAG (Spain) |
| 3 | Pellegrino, B | University Hospital of Parma; University of Parma Department of Medicine and Surgery (Italy) |
| 4 | Mateo, F | Institut d'Investigacio Biomedica de Bellvitge (IDIBELL) (Spain) |
| 5 | Martínez-Sanz, P | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 6 | Herencia-Ropero, A | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 7 | Odena, A | Vall d'Hebron Institut d'Oncologia (VHIO); Univ Barcelona UB (Spain) |
| 8 | Clavell-Revelles, P | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 9 | Casali, G | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 10 | Domènech, H | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 11 | Monserrat, L | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 12 | Papic, D | Free University of Berlin; Humboldt University of Berlin; Charite University Hospital Berlin Department of Pathology (Germany) |
| 13 | Malavila, AM | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 14 | Pascual-Reguant, A | Ctr Nacl Anal Genom CNAG (Spain) |
| 15 | Eixarch, H | Autonomous University of Barcelona; Vall d'Hebron Institut de Recerca (VHIR) (Spain) |
| 16 | Guzmán, M | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 17 | Rodríguez, O | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 18 | Grueso, J | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 19 | Simonetti, S | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 20 | Fasani, R | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 21 | Nuciforo, P | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 22 | Espejo, C | Autonomous University of Barcelona; Vall d'Hebron Institut de Recerca (VHIR) (Spain) |
| 23 | Florian, S | Free University of Berlin; Humboldt University of Berlin; Charite University Hospital Berlin Department of Pathology (Germany) |
| 24 | Pujana, MA | Institut d'Investigacio Biomedica de Bellvitge (IDIBELL) (Spain) |
| 25 | Nonell, L | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 26 | Seoane, J | ICREA; Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 27 | Valge-Archer, V | AstraZeneca (England) |
| 28 | O'Connor, MJ | AstraZeneca (England) |
| 29 | Nieto, JC | Ctr Nacl Anal Genom CNAG (Spain) |
| 30 | Heyn, H | Ctr Nacl Anal Genom CNAG (Spain) |
| 31 | Balmaña, J | Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |
| 32 | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) | |
| 33 | Vall d'Hebron Institut d'Oncologia (VHIO) (Spain) |